CD Buzz Video
Ashland’s new ingredient innovations have the luxury wellness consumer in mind
This content item was originally published on www.cosmeticsdesign.com, a William Reed online publication.
“We are launching two products,” affirms Joel Mantelin, vice president of biofunctionals at Ashland. “The first one is CB2-Skin, a patchouli extract” that activates the cannabinoid receptor 2; “and also Rosaliss, which is a product from the rose of Grasse.”
Describing the new CB2-Skin ingredient, Mantelin tells Cosmetics Design editor Deanna Utroske that, “the great advantage of this ingredient is that it is globally compliant. But on top of this, it’s a product that reminds also of the 70s and the 80s,” which, he explains, makes it an ingredient concept that fits in very neatly with the boho chic movement, i.e. the luxury wellness movement.
The company’s new Rosaliss ingredient is also well positioned for use in luxury skin care product formulations. “There are many rose extracts on the market,” acknowledges Mantelin, who then goes on to explain how the sourcing and processing of Rosaliss sets it apart in the marketplace: “We are using the proprietary technology, which is called PSR, or Plant Small RNA, technology, which captures what makes a plant unique in its environment.”
Watch the full video interview above to learn more and the development, testing, and benefits of the new Ashland skin care ingredients.
Deanna Utroske, CosmeticsDesign.com Editor, covers beauty business news in the Americas region and publishes the weekly Indie Beauty Profile column, showcasing the inspiring work of entrepreneurs and innovative brands.